TrialBMC cancer2013

Bifractionated CPT-11 with LV5FU2 infusion (FOLFIRI-3) in combination with bevacizumab: clinical outcomes in first-line metastatic colorectal cancers according to plasma angiopoietin-2 levels.

Stefano Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.